Steven Cohen Viatris Inc Call Options Transaction History

Point72 Asset Management, L.P.

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$11.27 - $13.53 $255,829 - $307,131	-22,700 Reduced 25.45%	66,500 $794,000
Q3 2023 Nov 14, 2023	BUY	$9.59 - $11.35 $690,480 - $817,200	72,000 Added 418.6%	89,200 $879,000
Q1 2023 May 15, 2023	BUY	$9.2 - $12.26 $16,560 - $22,068	1,800 Added 11.69%	17,200 $165,000
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $134,288 - $178,024	15,400 New	15,400 $171,000
Q2 2022 Aug 15, 2022	SELL	$9.95 - $12.27 $15.6 Million - $19.2 Million	-1,565,600 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $5.89 Million - $9.24 Million	599,900 Added 62.12%	1,565,600 $17 Million
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $11.7 Million - $14.2 Million	965,700 New	965,700 $13.1 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.